International Coalition of Medicines Regulatory Authorities COVID-19 Working Group - Summary of Achievements
In response to the COVID-19 pandemic, ICMRA established the COVID-19 Working Group to advance certain priority topics resulting from the ICMRA COVID-19 Policy meetings. The Working Group met regularly over the course of 2 years, and helped ICMRA to establish itself as a trusted group of leaders that voiced joint positions on COVID-19 regulatory authorisations, clinical trials and vaccine confidence, etc. through various statements. This summary report gives an overview of the impressive achievements of the COVID-19 Working Group.
International Coalition of Medicines Regulatory Authorities COVID-19 Working Group - Summary of Achievements (21 October 2022)
Other languages